Vilon
A synthetic dipeptide promoted for immune, thymic and healthy-ageing effects, supported mainly by preclinical and regional literature.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence2/5
Evidence Snapshot
- Overall
- 2/5Emerging / preliminary
- Human
- 0/5None identified
- Animal
- 2/5Some animal evidence
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Molecular formula
- C11H21N3O5
- Molecular weight
- 275.30 Da
- Sequence
- Lys-Glu
- Peptide family
- Khavinson short peptide bioregulator
- Entity class
- Synthetic dipeptide
- Alternative names
- KE peptideLys-Glu
Developed as a synthetic Lys-Glu dipeptide associated with thymic and immune bioregulator research.
Proposed Mechanisms
- not-yet-documentedpending-editorial-review
- Short peptide gene-expression modulation →limited
- Immune modulation →limited
Reported / Studied Uses
- Immune Function / InflammationEvidence · insufficient
Human Evidence
Human evidence is sparse, methodologically uncertain and not independently replicated at modern clinical-trial standards.
Animal Evidence
Animal studies report immune, tumour and lifespan-related effects that have not been confirmed clinically.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.